Natural product-based therapy for Cerebral Ischemia: Psammaplin A (PsA), isolated from marine sponges, increases cerebral blood flow and inhibits cerebral ischemia via up regulation of its target gene, 10/February/2016, 22.34

Mechanistic insight into Metastasis: IL-17 increases the expression of VEGFα, an activator of angiogeneis, via down regulation of its target gene, 10/February/2015, 22.28
February 10, 2015
Natural product-based therapy for Myocardial Infarction: Psammaplin A (PsA), isolated from marine sponges, improves myocardial function after myocardial infarction via up regulation of PNUTS/PPP1R10 (Serine/threonine-protein phosphatase 1 regulatory subunit 10), 10/February/2015, 22.40
February 10, 2015
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, Natural product-based therapy for Cerebral Ischemia: Psammaplin A (PsA), isolated from marine sponges,  increases  cerebral blood flow and inhibits cerebral ischemia via up regulation of its target gene, 10/February/2016, 22.34, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Significance: This study suggests that Psammaplin A, by increasing the expression of its target gene, it may preserve cerebral blood flow.  Thereby, it may inhibit the development of cerebral ischemiaThus, this study suggests that pharmacological formulations encompassing Psammaplin A or its analogues may be used to inhibit cerebral ischemia.

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Undisclosed information: How Psammaplin A preserves cerebral blood flow and inhibits cerebral ischemia

Amount: $500*

Comments are closed.